Literature DB >> 19179942

Treatment of severe, treatment-refractory obsessive-compulsive disorder: a study of inpatient and community treatment.

Mark J Boschen1, Lynne M Drummond, Anusha Pillay.   

Abstract

INTRODUCTION: This research reports on a prospective outcome study of two cohorts of patients with severe, chronic, resistant obsessive-compulsive disorder (OCD).
METHODS: One cohort consisted of a total of 52 patients treated in an inpatient setting, while the second group comprised 65 patients treated in a community-outpatient setting. Treatment consistent primarily of intensive graded exposure and self-imposed response prevention augmented with cognitive restructuring.
RESULTS: The groups demonstrated significant improvement over the course of treatment. In the inpatient and community groups, there was significant improvement over the first 12 weeks of treatment, and further improvement between 12 and 24 weeks.
CONCLUSION: These results suggest that even for patients who have demonstrated treatment-resistance, there may be benefit in intensive behavioral treatment of OCD. In addition it was found that even for those patients with the most profound refractory OCD and complicating factors inpatient stays of up to 24 weeks were effective in reducing symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 19179942     DOI: 10.1017/s1092852900017119

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  8 in total

1.  Physical complications of severe enduring obsessive-compulsive disorder.

Authors:  Lynne M Drummond; Azmatthulla Kham Hameed; Ruxandra Ion
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

2.  Understanding challenges around implementation of specialist service recommendations for obsessive-compulsive disorder.

Authors:  Karen J Walker; David M B Christmas
Journal:  BJPsych Bull       Date:  2017-04

3.  Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Authors:  Brian P Brennan; Catherine Lee; Jason A Elias; Jesse M Crosby; Brittany M Mathes; Marie-Christine Andre; Christina M Gironda; Harrison G Pope; Michael A Jenike; Garrett M Fitzmaurice; James I Hudson
Journal:  J Psychiatr Res       Date:  2014-05-23       Impact factor: 4.791

Review 4.  Pharmacological management of treatment-resistant obsessive-compulsive disorder.

Authors:  Anat Abudy; Alzbeta Juven-Wetzler; Joseph Zohar
Journal:  CNS Drugs       Date:  2011-07       Impact factor: 5.749

5.  [Guideline-adherent inpatient psychiatric psychotherapeutic treatment of obsessive-compulsive disorder : Normative definition of personnel requirements].

Authors:  J P Klein; B Zurowski; J Wolff; F Godemann; S C Herpertz; M Berger; G Heuft; F Hohagen
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

6.  Predictors of Intensive Treatment in Patients With Obsessive-Compulsive Disorder.

Authors:  Johanna A M du Mortier; Karin C P Remmerswaal; Neeltje M Batelaan; Henny A D Visser; Jos W R Twisk; Patricia van Oppen; Anton J L M van Balkom
Journal:  Front Psychiatry       Date:  2021-04-12       Impact factor: 4.157

7.  Compliance of community teams with specialist service recommendations for obsessive-compulsive and body dysmorphic disorders.

Authors:  Paul M Harris; Lynne M Drummond
Journal:  BJPsych Bull       Date:  2016-10

8.  Three-Week Inpatient Treatment of Obsessive-Compulsive Disorder: A 6-Month Follow-Up Study.

Authors:  Torun Grøtte; Bjarne Hansen; Svein Haseth; Patrick A Vogel; Ismail C Guzey; Stian Solem
Journal:  Front Psychol       Date:  2018-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.